Source author record

Ferenc A. Bartha

Ferenc A. Bartha appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

math.DS cs.CY math.NA Populations and Evolution Quantitative Methods

Catalog footprint

What is connected

3works

5topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

Dynamics of an SIRWS model with waning of immunity and varying immune boosting period

SIRS models capture transmission dynamics of infectious diseases for which immunity is not lifelong. Extending these models by a W compartment for individuals with waning immunity, the boosting of the immune system upon repeated exposure may be incorporated. Previous analyses assumed identical waning rates from R to W and from W to S. This implicitly assumes equal length for the period of full immunity and of waned immunity. We relax this restriction, and allow an asymmetric partitioning of the total immune period. Stability switches of the endemic equilibrium are investigated with a combination of analytic and numerical tools. Then, continuation methods are applied to track bifurcations along the equilibrium branch. We find rich dynamics: Hopf bifurcations, endemic double bubbles, and regions of bistability. Our results highlight that the length of the period in which waning immunity can be boosted is a crucial parameter significantly influencing long term epidemiological dynamics.

preprint2022arXiv

In silico evaluation of Paxlovid's pharmacometrics for SARS-CoV-2: a multiscale approach

Paxlovid is a promising, orally bioavailable novel drug for SARS--CoV--2 with excellent safety profiles. Our main goal here is to explore the pharmacometric features of this new antiviral. To provide a detailed assessment of Paxlovid, we propose a hybrid multiscale mathematical approach. We demonstrate that the results of the present \textit{in silico} evaluation match the clinical expectations remarkably well: on the one hand, our computations successfully replicate the outcome of an actual \textit{in vitro} experiment; on the other hand we verify both the sufficiency and the necessity of Paxlovid's two main components (nirmatrelvir and ritonavir) for a simplified \textit{in vivo} case. Moreover, in the simulated context of our computational framework we visualize the importance of early interventions, and identify the time window where a unit--length delay causes the highest level of tissue damage. Finally, the results' sensitivity to the diffusion coefficient of the virus is explored in details.

preprint2012arXiv

Local stability implies global stability for the 2-dimensional Ricker map

Consider the difference equation $x_{k+1}=x_k e^{α-x_{n-d}}$ where $α$ is a positive parameter and d is a non-negative integer. The case d = 0 was introduced by W.E. Ricker in 1954. For the delayed version d >= 1 of the equation S. Levin and R. May conjectured in 1976 that local stability of the nontrivial equilibrium implies its global stability. Based on rigorous, computer aided calculations and analytical tools, we prove the conjecture for d = 1.